A Case Definition of a New Disease: A Review of the US Working Definition (USG) and 2024 NASEM Definition for Long COVID
Covid19-Sources
Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study
Studie sieht Effekt bei Frauen: Covid lässt womöglich Gefäße schneller altern
Silent Invasion: COVID-19’s Hidden Damage to Human Organs
Incidence of Long COVID Following Reinfection with COVID-19
Estimated transmission dynamics of SARS-CoV-2 variants from wastewater are unbiased and robust to differential shedding
Long-Term Impact of COVID-19 on Osteoporosis Risk Among Patients Aged ≥50 Years with New-Onset Overweight, Obesity, or Type 2 Diabetes: A Multi-Institutional Retrospective Cohort Study
Children with Post COVID-19 Multisystem Inflammatory Syndrome Display Unique Pathophysiological Metabolic Phenotypes
Association Between COVID-19 Infection and Thyroid Cancer Development: A Retrospective Cohort Study Using the TriNetX Database
Radware Bot Manager Captcha
Hoffnungsschimmer für Long-Covid-Patienten: Behandlungserfolg in Erlangen
Validation of the age, neutrophil to lymphocyte ratio, C reactive protein score on 28 day mortality in the National COVID cohort collaborative
COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type | Arteriosclerosis, Thrombosis, and Vascular Biology
Prefrontal dysfunction in post-COVID-19 hyposmia: an EEG/fNIRS study
"CHAOTIC" PATTERNS of the COVID-19 PANDEMIC
Cognitive deficits after COVID-19 associated with brain injury biomarkers and volume loss
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response
Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19—A Scoping Review
Assessment of serum parameters caused by the outbreak of mycoplasma pneumoniae pneumonia in children after COVID-19
Sulforaphane—A Compound with Potential Health Benefits for Disease Prevention and Treatment: Insights from Pharmacological and Toxicological Experimental Studies
Sulforaphane: Its “Coming of Age” as a Clinically Relevant Nutraceutical in the Prevention and Treatment of Chronic Disease
Systematic review of post-COVID condition in Nordic population-based registry studies
Safety of JN.1-Updated mRNA COVID-19 Vaccines
Silent Invasion: COVID-19’s Hidden Damage to Human Organs
Der Schmerz war stärker als die Hoffnung! ME/CFS-Patientin Sarah (31) stirbt durch Sterbehilfe
Inflammatory, fibrotic and endothelial biomarker profiles in COVID-19 patients during and following hospitalization
Neuroimaging insights into the psychosocial impact of the COVID-19 pandemic: a systematic review
Ralf Wittenbrink (@ralfwittenbrink.bsky.social)
First wave of COVID-19 increased risk of heart attack, stroke up to three years later
When SARS-CoV-2 appeared, I had no interest in vaccines for the reasons described below, but when the vaccine mass hysteria began, I spent a few months studying the immune system. I was horrified to discover how little we know, especially all the "experts" who "know".